Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;18(8):20220048.
doi: 10.1098/rsbl.2022.0048. Epub 2022 Aug 10.

Hepatitis C virus infection reduces the lifespan of chimpanzees used in biomedical research

Satoshi Hirata  1   2 , Kristin Havercamp  1 , Yumi Yamanashi  1   3 , Toshifumi Udono  1   2
Affiliations

Hepatitis C virus infection reduces the lifespan of chimpanzees used in biomedical research

Satoshi Hirata et al. Biol Lett. 2022 Aug.

Abstract

Chimpanzees were used in hepatitis research for over three decades with the aim to identify and develop treatments for the virus, a leading cause of chronic liver disease in humans. We used a dataset of 120 chimpanzees housed at a single institution in Japan, 22 of whom became chronically infected with hepatitis C virus (HCV), to examine whether HCV infection results in a reduced lifespan as reported in humans. Survival analysis showed that HCV carriers experienced a higher mortality risk compared with non-carriers. Although no chimpanzee died from hepatic disease, carriers showed higher gamma-glutamyl transpeptidase (γGTP) levels compared with non-carriers suggesting that HCV infection negatively affected their liver condition. These results provide evidence that special attention is necessary to monitor the long-term condition of ex-biomedical primates.

Keywords: biomedical research; chimpanzee; hepatitis; lifespan; longevity; mortality.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Survival curves of HCV carrier and non-carrier chimpanzees.
Figure 2.
Figure 2.
γGTP values (IU l–1) for individual chimpanzees (HCV carriers in red and non-carriers in blue). Boxplot shows the median, interquartile-range and outliers.
See this image and copyright information in PMC

References

    1. The Polaris Observatory HCV Collaborators. 2022. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol. Hepatol. 7, 396-415. ( 10.1016/S2468-1253(21)00472-6) - DOI - PubMed
    1. Bailey J. 2010. An assessment of the use of chimpanzees in hepatitis C research past, present and future: 1. Validity of the chimpanzee model. Altern Lab Anim. 38, 387-418. ( 10.1177/026119291003800501) - DOI - PubMed
    1. Bailey J. 2011. Lessons from chimpanzee-based research on human disease: the implications of genetic differences. Altern Lab Anim. 39, 527-540. ( 10.1177/026119291103900608) - DOI - PubMed
    1. Lanford RE, Walker CM, Lemon SM. 2017. The chimpanzee model of viral hepatitis: advances in understanding the immune response and treatment of viral hepatitis. ILAR J. 58, 172-189. ( 10.1093/ilar/ilx028) - DOI - PMC - PubMed
    1. Houghton M, Abrignani S. 2005. Prospects for a vaccine against the hepatitis C virus. Nature 436, 961-966. ( 10.1038/nature04081) - DOI - PubMed

Publication types